Drug Insights

Optimize Your Synapse Experience: A Step-by-Step Guide to Searching Melatonin

1 February 2024
2 min read

Melatonin is a small molecule drug that acts on melatonin receptors, functioning as an agonist. It is primarily used to treat sleep initiation and maintenance disorders, including insomnia, and has also been investigated as a potential treatment for autism spectrum disorder and delirium. In addition, it has been studied as a potential therapy for COVID-19, with some evidence suggesting that it may have a beneficial effect in reducing symptoms and severity of the disease. Melatonin was first approved as a drug in 2005, and its safety and efficacy have been well-established in numerous clinical studies over the years. Click on the image below to begin the exploration journey of Melatonin through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

CBR-701 (SYS6002): A Novel Nectin-4-Targeted Therapy Showing Promise in Initial Human Trials for Cancer Patients
Latest Hotspot
3 min read
CBR-701 (SYS6002): A Novel Nectin-4-Targeted Therapy Showing Promise in Initial Human Trials for Cancer Patients
1 February 2024
CBR-701 (SYS6002), a cutting-edge therapeutic agent aimed at Nectin-4, exhibits promising outcomes in initial human trials with Nectin-4 positive cancer patients.
Read →
The Synapse User's Toolkit: Tips for Searching Naproxen
Drug Insights
2 min read
The Synapse User's Toolkit: Tips for Searching Naproxen
1 February 2024
Naproxen is a small molecule drug that inhibits COX enzymes, with active indications including pain, gout, inflammation, ankylosing spondylitis, and juvenile arthritis.
Read →
Unlock the Power of Synapse: A Guide to Searching Famotidine
Drug Insights
2 min read
Unlock the Power of Synapse: A Guide to Searching Famotidine
1 February 2024
Famotidine is a medicine that helps people with stomach problems like gastritis and peptic ulcers.
Read →
Flare Therapeutics Reveals FX-909's Early-Stage Trial Design at 2024 ASCO Urologic Cancer Conference
Latest Hotspot
3 min read
Flare Therapeutics Reveals FX-909's Early-Stage Trial Design at 2024 ASCO Urologic Cancer Conference
1 February 2024
Flare Therapeutics Unveils Design for FX-909's Early-Stage Trial with Dose Increasing and Widening Approach at ASCO's 2024 Urologic Cancer Conference.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.